The EMA's Committee for Medicinal Products for Human Use or CHMP recommended the approval of Jentadueto for use alongside diet and exercise to improve glycemic control in adults with type 2 diabetes who are inadequately controlled on their maximally
Jentadueto Recommended For Approval In Treatment Of Adults With Type 2 Diabetes
Related posts:
- Hepatitis B Vaccine Recommended For Diabetic Adults Washingotn, DC, United States (AHN) – New government guidelines recommend...
- Linagliptin Receives Approval In Europe For The Treatment Of Type 2 ?The Phase III clinical trial program has demonstrated efficacy with...
- Hepatitis B Vaccine Recommended For Adults With Diabetes "Stable type 2 diabetics on oral medication may not need...
- Onglyza Earns European Approval For Type 2 Diabetes Treatment Bristol-Myers Squibb and AstraZeneca have confirmed approval by the European...
- Linagliptin Does Not Offer Added Benefit For Adults With Type 2 Diabetes Linagliptin has been approved since August 2011 to improve blood...